Compliance & Validation — Documented
SOC 2 Type II
Tellius
AI decision-intelligence platform with natural-language analytics, used by pharma commercial and market access teams.
Tellius, founded in 2016 and headquartered in Reston, Virginia, provides a decision-intelligence platform combining natural-language search, automated insight discovery, and machine learning over enterprise data, with life sciences commercial analytics — brand performance, patient journey, market access — among its primary verticals. The company announced SOC 2 Type II in 2023 and has raised roughly $36 million through Series B. It is a horizontal analytics platform rather than pharma-specific software, so validate life-sciences data model depth during evaluation.
- Headquarters
- Reston, United States
- Founded
- 2016
- Compliance
- SOC 2 Type II
- Deployment options
- cloud
- Website
- https://www.tellius.com
- https://www.linkedin.com/company/tellius
Categories
AI Use Cases
- Patient Identification & Segmentation
Vendor Scorecard
71% — Complete coverage. Coverage score — how completely Atlas documents Tellius across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud
Pricing Transparency — Not documented by Atlas
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Implementation & Onboarding — Not documented by Atlas
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Organization & Role Fit — Documented
Mid-Size Biotech, Large Pharma, Top 20 Pharma, Commercial, Data Management
Solution Scope — Documented
Natural Language Processing
Company Viability — Documented
Series B, $36.1M raised, Founded 2016
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Questions to Ask This Vendor
- What pharma commercial data models ship out of the box?
- How do natural-language queries handle claims and prescribing data?
- What period does the SOC 2 Type II report cover?
- How does it complement or replace our existing BI stack?